Luxury fashion brands Michael Kors and Versace logo showcasing price increases amidst booming demand - Global Banking & Finance Review
This image represents the luxury fashion industry, highlighting Capri Holdings' plans to increase prices for Michael Kors and Versace in response to booming consumer demand. The article discusses Capri's strong sales growth and brand repositioning strategies.
Research Reports

Neurology Devices Market – Know-How Industry to Experience Positive Growth | robust CAGR of 15.9% over the forecast period (2017 – 2025).

Published by Coherent Market Insights

Posted on September 16, 2021

4 min read

· Last updated: September 16, 2021

Add as preferred source on Google

Neurology Devices Market Set for Strong Growth with 15.9% CAGR

Drivers:

Research and development of advanced nervous system science gadgets are driving the growth of the neurology devices market. For example, in March 2020, specialists at the Institute for Genomic Medicine at Columbia University Irving Medical Center revealed the advancement of improvement mode particle-based semiconductor intended to record the electrical action of neurons and to perform continuous estimations that help in distinguishing and checking neurological issues

Opportunities:

For players in the global neurology devices industry, the development of novel imaging software for neurological disorders is expected to provide lucrative growth opportunities. For example, Qynapse, a medical technology company based in France, obtained 510(k) clearance from the US Food and Drug Administration in February 2020 for its QyScore neurodegenerative disease imaging software.

Restraints:

Product recalls are likely to stifle business expansion. The US Food and Drug Administration (FDA) issued a Class 1 recall for Zimmer Biomet’s ROSA Brain system in November 2019, citing a software problem.

Request for Sample Copy Here

Key Takeaways:

The global neurology devices market was worth US$ 13,572.1 million in 2019 and is projected to hit US$ 44,045.9 million by 2027, with a CAGR of 15.9% from 2020 to 2027. Over the forecast period, the global neurology devices market is expected to expand due to increased R&D of new neurology devices.

In terms of size, the Neuro-stimulation Devices segment dominated the global neurology devices market in 2019, accounting for 71.4 percent of the market, followed by Interventional Neurology Devices and CSF Management Devices. The segment’s growth will be fueled by the rising prevalence of neurological disorders.

Market Trends:

Key Players in the market are introducing nervous system science gadgets to help medical care frameworks during the Covid-19 pandemic. For example, in May 2020, BIONIK Laboratories Corp. launched an In Motion automated framework, used to help stroke survivors and those with other neurological conditions recover arm and hand movement

Key players in the market are focused on endorsement and dispatch of new gadgets to grow their item portfolio. For example, in February 2020, Avanos Medical, Inc. received the U.S. Food and Drug Administration (FDA) endorsement for its 80-Watt COOLIEF Radiofrequency (RF) framework for neurological injury methodology.

Get Flat USD 2000 OFF

Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/3889

Reasons to Purchase this Report

Current and future of global Neurology Devices Market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Competitive Landscape:

Key Players engaged in the neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, BIONIK Laboratories Corp., Integra LifeSciences Holdings Corporation, Johnson and Johnson, Magstim Co Ltd., Braintale SAS, Medtronic, plc. Abbott, Zimmer Biomet, Stryker Corporation, Helius Medical Technologies, Inc., Avanos Medical, Inc., W.L. Carnage and Associates, Inc., HeadsafeIP Pty Ltd., Cerus Endovascular Ltd., and Cyberonics, Inc.

Key Developments:

  1. In May 2020, HeadsafeIP Pty Ltd., a held mind wellbeing innovation organization, received 510(k) leeway from the U.S. Food and Drug Administration (FDA) for its NUROCHEK framework for mind appraisal.
  2. In April 2020, Cerus Endovascular Ltd. received CE Mark endorsement for its 021 Contour Neurovascular System, viable with more modest industrially accessible 021 microcatheters for the treatment of saccular intracranial aneurysms

Contact:

Coherent Market Insights

1001 4th Ave, #3200 Seattle, WA 98154, U.S.

Email: sales@coherentmarketinsights.com

United States of America: +1-206-701-6702

United Kingdom: +44-020-8133-4027

Japan: +050-5539-1737

India: +91-848-285-0837

The post Neurology Devices Market – Know-How Industry to Experience Positive Growth | robust CAGR of 15.9% over the forecast period (2017 – 2025). appeared first on Gatorledger.

Frequently Asked Questions

What is the projected market value of the neurology devices market by 2027?
The global neurology devices market is projected to reach US$ 44,045.9 million by 2027.
What is the expected CAGR for the neurology devices market?
The neurology devices market is expected to grow at a robust CAGR of 15.9% from 2020 to 2027.
What segment dominated the neurology devices market in 2019?
In 2019, the Neuro-stimulation Devices segment dominated the market, accounting for 71.4 percent.
What are some challenges faced by the neurology devices market?
Product recalls, such as the Class 1 recall for Zimmer Biomet’s ROSA Brain system, are likely to stifle business expansion.
Which companies are key players in the neurology devices market?
Key players include B. Braun Melsungen AG, Boston Scientific Corporation, and Johnson and Johnson.

Tags

Related Articles

More from Research Reports

Explore more articles in the Research Reports category